12
Views
0
CrossRef citations to date
0
Altmetric
Peer-Reviewed Articles

Are Reuse Quality Standards Too High, or Are Potable Water Quality Standards Too Lax?

Pages 16-21 | Published online: 18 Jul 2013

References

  • Athavaley, A., 2008. Sewer to Spigot: Recycled Water. The Wall Street Journal, May 15, 2008, online edition, D1.
  • Benotti, M.J.; Trenholm, R.A.; Holady, J.C.; Stanford, B.D.; and Snyder, S.A., 2009. Pharmaceuticals and Endocrine Disrupting Compounds in US Drinking Water, Applied Research and Development Center, Southern Nevada Water Authority, Las Vegas, Nev. Environmental Science and Technology, 43: 597–603.
  • Borenstein, S., 2009. Cheers! Crew drinks up recycled urine in space. The Associated Press, May 20, 2009.
  • Crook, J., 2007. History of Reuse and Public Health Implications. Water Environment Federation, WEFTEC 2007 Workshop W-116. San Diego, Calif.
  • Donn, J.; Mendoza, M.; and Pritchard, J., 2009. AP Impact: Tons of released drugs taint US water. The Associated Press, April 20, 2009.
  • Navarrete, E.M. and Higgins, M.J., 2006. Phthalates in Central Pennsylvania Water Sources. WateReuse Association Symposium, Hollywood, Calif.
  • Royte, E., 2008. A Tall, Cool Drink of ... Sewage? The New York Times, Aug. 10, 2008.
  • Salveson, A.; Brown, J.; and Zhou, Z., 2009. Monitoring for Microconstituents in an Advanced Wastewater Treatment (AWT) Facility and Modeling Discharge of Reclaimed Water to Surface Canals for Indirect Potable Use. WateReuse Foundation, WRF 06-019, Alexandria, Va.
  • Smith, H., 2009. Poisoned Waters. Public Broadcasting System, Frontline, April 21,2009.
  • Snyder, E., 2005. Potential Human Health Effects of Emerging Chemical Contaminants in Reuse Water. Water Environment Federation WEFTEC 2005, Workshop 105. Washington, D.C.
  • Snyder, S., 2008a. Occurrence and Relevance of Endocrine Disruptors and Pharmaceuticals in Water. WateReuse Association Symposium, Dallas, Texas.
  • Snyder, S., 2008b. Senate Subcommittee on Transportation Safety, Infrastructure Security, and Water Quality. Washington, D.C.
  • Snyder, S.; Lei, H.; Hemming, J.; Zeigler-Holiday, J.; and Trenholm, R., 2007. Relative Risk Assessment of Estrogens in Reuse Water. WateReuse Association Symposium, Tampa, Fla.
  • US Environmental Protection Agency, 2008. Emerging Contaminant N-Nitroso-dimethylamine (NDMA) Fact Sheet EPA 505-F-07-006, Washington, D.C.
  • USEPA 2004. Guidelines for Water Reuse (Available at www.epa.gov/nrmrl/pubs/625r04108/625r04108.pdf).
  • US Geological Survey, 2009. USGS Scientists Develop New Method to Measure Pharmaceuticals in Water. Reston, Va. (Available online at http://toxics.usgs.gov/highlights/pharmaceuticals_method.html).
  • USGS, 2006. Toxic Substances Hydrology Program Errata for Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in US Streams, 1999–2000: A National Reconnaissance. Reston, Va. (Available online at http://toxics.usgs.gov/regional/est_errata.html; accessed May 11, 2009).
  • USGS, 2002. Glacial Ice Cores Reveal a Record of Natural and Anthropogenic Atmospheric Mercury Deposition for the Last 270 Years, Fact Sheet FS-051-02, Reston, Va.
  • USGS, 2000. National Reconnaissance of Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in Streams of the US, 1999–2000. Toxic Substances Hydrology Program (Available at http://toxics.usgs.gov/regional/emc_surfacewater.html).
  • Water Environment Research Foundation, 2008. Fate of Pharmaceuticals and Personal Care Products through Municipal Treatment Processes. WERF Progress, 03CTS22UR, 19:2, Alexandria, Va.
  • Water Environment Federation, 2005. Endocrine Disruptors and Emerging Contaminants in Your Reuse System. WEFTEC Workshop 105, Washington, D.C.
  • West, L. 2008. From Toilet to Tap: California Transforms Sewage into Drinking Water. Los Angeles Times, Feb. 7, 2008.
  • World Health Organization, 2002. Global Assessment of the State-of-the-Science of Endocrine Disruptors. International Programme on Chemical Safety (T. Damstra, S. Barlow, A. Bergman, R. Kavlock, G. Van Der Kraak, editors). ( Available online at www.who.int/ipcs/publications/new_issues/endocrine_disruptors/en/print.html.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.